Drug intelligence / Profile preview

P-ENVs

Development stage: Preclinical
Modality: Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems

Overview

P-ENVs (biomimetic platelet membrane-coated exosome-mimetic nanovesicles) are a novel therapeutic approach designed for the treatment of atherosclerosis. These nanovesicles are derived from mesenchymal stem cells (MSCs) and are coated with a platelet membrane. The biomimetic design aims to enhance targeted delivery to atherosclerotic plaques, addressing challenges associated with large-scale production and organ-specific targeting of traditional MSC-derived exosomes. P-ENVs are being investigated for their targeted efficiency and therapeutic potential in atherosclerosis.

Other names: biomimetic platelet membrane-coated exosome-mimetic nanovesiclesplatelet membrane-coated nanovesiclesexosome-mimetic nanovesicles

Beyond the preview

Go deeper on P-ENVs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on P-ENVs.

Explore the full profile